Skip to main content
. 2013 Dec 19;53(4):704–713. doi: 10.1093/rheumatology/ket411

Table 3.

Associations of serum proteins (P < 0.05) with the presence/absence of plaque and CIMT in SSc

CIMT (n = 44)
Biomarker (pg/ml) No plaque, mean (s.d.) (n = 25) Plaque, mean (s.d.) (n = 21) P-value Correlation coefficients P-value
Fibrosis
    MPIF-1 901.2 (143.7) 265.8 (223.3) 0.17 0.31 0.04*
    CC16 14 492.7 (6631.9) 14 845.4 (7555.1) 0.93 0.37 0.01*
Inflammation
    IL-2 3.0 (2.6) 5.0 (3.8) 0.02* −0.17 0.25
    CRP 1 627 772.0 (2 437 838.6) 3 856 899.5 (4 734 651.2) 0.00* 0.14 0.35
    IL-6 11.0 (13.5) 25.2 (48.5) 0.04* 0.28 0.06*
    A-SAA 18 790 613.4 (30 238 222.3) 23 431 668.8 (30 070 001.2) 0.43 0.31 0.04*
Vasculopathy
    KGF 0.8 (2.1) 1.6 (2.1) 0.01* 0.19 0.22
    ICAM-1 403 423.3 (131 159.9) 539 501.8 (242 768.3) 0.04* 0.16 0.29
    PAI-1 9607.8 (6527.1) 6680.8 (5898.0) 0.04* −0.10 0.29
    Endoglin 22 444.1 (9253.0) 8860.8 (0.0394) 0.03* 0.07 0.51
    IGFBP-3 404 848.8 (116 838.8) 322 117.3 (93 709.0) 0.00* 0.13 0.66
    TM 4826.3 (1865.1) (n = 24) 4412.1 (1262.7) 0.00 0.32 0.03*

CIMT: carotid intima media thickness; MPIF-1: myeloid progenitor inhibitory factor 1; CC16: Clara cell secretory protein 16 kDa; A-SAA: serum amyloid A; KGF: keratinocyte growth factor; ICAM-1: intercellular adhesion molecule 1; PAI-1: plasminogen activator inhibitor 1; IGFBP-3: insulin-like growth factor binding protein 3; TM: thrombomodulin. *P-values <0.05.